Vertex Pharmaceuticals, Inc. (VRTX) Misses Q2 EPS by 8c, Offers Guidance

July 29, 2013 4:05 PM

Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q2 EPS of ($0.26), $0.08 worse than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found